N/A
Completed N=321
Personalized Smoking Cessation Tool Based on Patient Lung CT Image
Source: ClinicalTrials.gov NCT03087617 ↗Enrolled (actual)
321
Serious AEs
0.0%
Results posted
Oct 2022
Primary outcomePrimary: Report's Impact on Calling a Quitline Number
Summary
Imbio is developing a Smoking Cessation Report (Report) that includes data analysis from a CT lung cancer screening exam. This randomized controlled (RCT) trial will clinically validate the Report's effectiveness at motivating smokers to call a Quitline.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Report's Impact on Calling a Quitline Number |
— | — |
| PRIMARY Report's Impact Making a Quit Attempt Measured Via Follow-up Phone Call |
2.85; 3.00; 2.80; 3.07 | — |
Eligibility Criteria
Inclusion Criteria
- 30-pack year smoking history
- currently smoke OR quit within the last 15 years and a category 1 or 2 Lung-RADS scan
Exclusion Criteria
- current use of smoking cessation medications
- scan read as a category 3, 4A, 4B or 4X in Lung-RADS
- unstable medical or psychiatric conditions
- current alcohol or drug use disorder
- past-month suicidal ideation
- past-year suicide attempt
Data sourced from ClinicalTrials.gov (NCT03087617). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.